Description
An immunomodulator; reduces splenic counts of Ly6ChiCD115+ inflammatory monocytes and CD11b+CD11c+ dendritic cells in a mouse model of EAE; reduces hepatic fibrosis and accumulation of inflammatory monocytes and neutrophils in the N-IF mouse model of liver fibrosis at 25 mg/kg per day; delays disease onset and decreases insulitis in NOD mice; reduces skin thickness, the number of myofibroblasts, and autoantibody production in the tight skin 1 mouse model of systemic sclerosis at 5 and 25 mg/kg
Formal name: N,5-diethyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-N-phenyl-3-quinolinecarboxamide
Synonyms: ABR-25757
Molecular weight: 350.4
CAS: 248282-01-1
Purity: ≥98%
Formulation: A solid